Revenue loss for Senetek
A loss in product sales and royalties left US-based Senetek with a net loss for the quarter ended 31 March, 2003, of $69,000 or $0.00 per share,...
News & Analysis on Cosmetics Innovation
A loss in product sales and royalties left US-based Senetek with a net loss for the quarter ended 31 March, 2003, of $69,000 or $0.00 per share,...
First quarter sales at the German speciality chemicals company remained steady and earnings before interest and taxes rose 10 per cent on the prior year, giving chairman Professor Felcht cause for an optimistic outlook for 2003.